Keiichiro Mori

57PUBLICATIONS
139CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsImmunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Jul 31, 2026
Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population.

|Apr 01, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Roberto Contieri, Paolo Gontero, Rodolfo Hurle

|Mar 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancer.

Aleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri

|Feb 18, 2026
Real-World Comparative Study of Apalutamide Versus Bicalutamide in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer.

Hidetsugu Takahashi, Wataru Fukuokaya, Katsuki Muramoto

|Jan 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study.

Takuma Kato, Akira Yokomizo, Ryuji Matsumoto

|Oct 06, 2025
Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

Francesco Pellegrino, Mario de Angelis, Pietro Scilipoti

Pageof 10

Frequent Collaborators

22 joint publications

Ekaterina Laukhtina

13 joint publications

Reza Sari Motlagh

12 joint publications

Hadi Mostafai

12 joint publications

Takafumi Yanagisawa